SCHEMBL29357349

SCHEMBL29357349

CCOC(=O)C1=NN(c2ccccc2)C(=O)C1N=Nc1ccc(-c2ccc(N=NC3C(=O)N(c4ccccc4)N=C3C(=O)OCC)c(Cl)c2)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ NPC1 O15118 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ MEN1 O00255 5/20 0.42
▸ KMT2A Q03164 5/20 0.42
▸ GAA P10253 4/20 0.41
▸ ATM Q13315 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CYP1A2 P05177 2/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ GABRA2 P47869 3/20 0.38
▸ GABRB2 P47870 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL306680 1.00 MAPT (0.43) MAPTSMN1; SMN2ALDH1A1NPC1LMNA
SCHEMBL306681 1.00 MAPT (0.43) MAPTSMN1; SMN2ALDH1A1NPC1LMNA
SCHEMBL21436310 0.88 GAA (0.44) MAPTSMN1; SMN2ALDH1A1NPC1LMNA
SCHEMBL29351685 0.88 GAA (0.44) MAPTSMN1; SMN2ALDH1A1NPC1LMNA
SCHEMBL30388957 0.84 MAPT (0.56) MAPTSMN1; SMN2ALDH1A1NPC1LMNA
SCHEMBL30078720 0.82 MAPT (0.64) MAPTSMN1; SMN2ALDH1A1NPC1LMNA
SCHEMBL2641828 0.82 MAPT (0.64) MAPTSMN1; SMN2ALDH1A1NPC1LMNA
SCHEMBL2641824 0.82 MAPT (0.64) MAPTSMN1; SMN2ALDH1A1NPC1LMNA
SCHEMBL29350167 0.82 MAPT (0.64) MAPTSMN1; SMN2ALDH1A1NPC1LMNA
SCHEMBL2612569 0.80 KMT2A (0.45) MAPTSMN1; SMN2ALDH1A1NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3683262-B2 THERMOPLASTIC ELASTOMER COMPOSITION, FOAM PARTICLE, AND FOAM MOLDED BODY SEKISUI PLASTICS (JP) 2025-10-15 — — EP claimed
US-11803132-B2 Toner for developing an electrostatic charge image and an image forming method Konica Minolta, Inc. (JP) 2023-10-31 — — US claimed
US-11768447-B2 Toner for developing an electrostatic charge image and an image forming method Konica Minolta, Inc. (JP) 2023-09-26 — — US claimed
US-20220397837-A1 TWO-COMPONENT DEVELOPER AND IMAGE FORMING METHOD Konica Minolta, Inc. (JP) 2022-12-15 — — US claimed
CN-113604136-B Sand grain powder coating with super-delayed mechanical properties and preparation method thereof 安徽神剑新材料股份有限公司 2022-07-01 — — CN claimed
EP-3605234-B1 TONER, TONER SET, TONER ACCOMMODATING UNIT, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS RICOH CO LTD (JP) 2026-05-27 — — EP disclosed
US-12638790-B2 Electrostatic charge image developing toner, electrostatic charge image developer, toner cartridge, process cartridge, and image forming apparatus FUJIFILM BUSINESS INNOVATION CORP. (JP) 2026-05-26 — — US disclosed
CN-115963712-B Process cartridge 佳能株式会社 2026-05-22 — — CN disclosed
EP-4745672-A1 MAGNETIC CARRIER AND TWO COMPONENT DEVELOPER CONTAINING THE SAME, AND METHOD FOR PRODUCING MAGNETIC CARRIER KYOCERA Document Solutions Inc. (JP) 2026-05-20 — — EP disclosed
US-12631983-B2 Silica particle, toner for developing electrostatic charge image, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method FUJIFILM BUSINESS INNOVATION CORP. (JP) 2026-05-19 — — US disclosed
US-20260133513-A1 MAGNETIC CARRIER AND TWO COMPONENT DEVELOPER CONTAINING THE SAME, AND METHOD FOR PRODUCING MAGNETIC CARRIER KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2026-05-14 — — US disclosed
CN-117203062-B Contact member, drying apparatus and printing apparatus 株式会社理光 2026-05-12 — — CN disclosed
US-11249412-B2 Toner CANON KABUSHIKI KAISHA (JP) 2022-02-15 — — US disclosed
US-11249409-B2 Image forming apparatus and process cartridge FUJIFILM BUSINESS INNOVATION CORP. (JP) 2022-02-15 — — US disclosed
US-11248136-B2 Ink jet liquid composition and ink jet recording method FUJIFILM CORPORATION (JP) 2022-02-15 — — US disclosed
CN-111226511-B Electromagnetic wave absorbing sheet for millimeter wave band, electromagnetic wave absorbing method, and electromagnetic wave failure preventing method 关西涂料株式会社 2022-02-11 — — CN disclosed
CN-107922771-B Ultraviolet (UV) curable inkjet ink compositions 惠普发展公司,有限责任合伙企业 2022-02-11 — — CN disclosed
CN-114026171-A Melt extrusion molded article of methacrylic acid 株式会社可乐丽 2022-02-08 — — CN disclosed
EP-3762238-B1 INKJET PRE-TREATMENT FLUID FOR TEXTILE PRINTING HEWLETT PACKARD DEVELOPMENT CO (US) 2022-01-26 — — EP disclosed
EP-3941756-A1 THERMOSENSITIVE RECORDING MEDIUM Ricoh Company, Ltd. (JP) 2022-01-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260133513-A1 MAGNETIC CARRIER AND TWO COMPONENT DEVELOPER CONTAINING THE SAME, AND METHOD FOR PRODUCING MAGNETIC CARRIER COPA, CORO1A, SMC1A MAPT 29/4885SMN1; SMN2 1382/4885ALDH1A1 4079/4885
US-12638790-B2 Electrostatic charge image developing toner, electrostatic charge image developer, toner cartridge, process cartridge, and image forming apparatus H1-10, CECR2, C1R MAPT 548/4885SMN1; SMN2 2192/4885ALDH1A1 3917/4885
US-12631983-B2 Silica particle, toner for developing electrostatic charge image, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method BET1, SMARCC1, SMARCC2 MAPT 326/4885SMN1; SMN2 1890/4885ALDH1A1 4756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback